Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT07639255
Official study title

Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation

Study summary

This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedQUILS System

The study team can explain what participation involves.

Who it may be forLung Cancer Screening

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 1, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?17 U.S. locations

Locations may change over time.

Who runs it?Timothy Mullett

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
Timothy Mullett
Interventions being studied
Other: QUILS System
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program.
  • Willing to participate in the QUILS Index Assessment Survey process
  • Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews
Reasons someone may not be able to joinExclusion criteria
  • Unwilling to participate in the QUILS Index Assessment Survey process
  • Unwilling to participate in the QUILS Audit Feedback presentations
  • Unwilling to participate in formative evaluation interviews

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • King's Daughter's Medical CenterAshland, Kentucky
  • Taylor Regional HospitalCampbellsville, Kentucky
  • St. Elizabeth HealthcareEdgewood, Kentucky
  • Georgetown Cancer Treatment CancerGeorgetown, Kentucky
  • TJ Samson Community HospitalGlasgow, Kentucky
  • Hazard Appalachian Regional Healthcare Medical CenterHazard, Kentucky
  • Lexington VA Health Care SystemLexington, Kentucky
  • St. Joseph Health (Catholic Health Initiatives)Lexington, Kentucky
  • University of Kentucky Markey Cancer CenterLexington, Kentucky
  • The James Graham Brown Cancer Center at University of LouisvilleLouisville, Kentucky
  • Meadowview Regional Medical CenterMaysville, Kentucky
  • Saint Claire Regional Medical CenterMorehead, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 1, 2026. Always confirm current availability with the study team.

View original record ↗